These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16052549)

  • 1. Aggregation kinetics of recombinant human FVIII (rFVIII).
    Ramani K; Purohit V; Middaugh CR; Balasubramanian SV
    J Pharm Sci; 2005 Sep; 94(9):2023-9. PubMed ID: 16052549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid binding region (2303-2332) is involved in aggregation of recombinant human FVIII (rFVIII).
    Ramani K; Purohit VS; Miclea RD; Middaugh CR; Balasubramanian SV
    J Pharm Sci; 2005 Jun; 94(6):1288-99. PubMed ID: 15858858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIII.
    Kosloski MP; Miclea RD; Balu-Iyer SV
    AAPS J; 2009 Sep; 11(3):424-31. PubMed ID: 19499345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Full-Length FVIII Benefits from Its Heterogeneity - Insights into the Role of the B-Domain.
    Anzengruber J; Feichtinger M; Bärnthaler P; Haider N; Ilas J; Pruckner N; Benamara K; Scheiflinger F; Reipert BM; Malisauskas M
    Pharm Res; 2019 Apr; 36(5):77. PubMed ID: 30937539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.
    Demasi MA; de S Molina E; Bowman-Colin C; Lojudice FH; Muras A; Sogayar MC
    Mol Biotechnol; 2016 Jun; 58(6):404-14. PubMed ID: 27126696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of marketed factor VIII products: recombinant products are not alike vis-a-vis soluble protein aggregates and subvisible particles.
    Anzengruber J; Lubich C; Prenninger T; Gringeri A; Scheiflinger F; Reipert BM; Malisauskas M
    J Thromb Haemost; 2018 Jun; 16(6):1176-1181. PubMed ID: 29665242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice.
    Purohit VS; Middaugh CR; Balasubramanian SV
    J Pharm Sci; 2006 Feb; 95(2):358-71. PubMed ID: 16372314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical characterisation of rVIII-SingleChain, a novel recombinant single-chain factor VIII.
    Schmidbauer S; Witzel R; Robbel L; Sebastian P; Grammel N; Metzner HJ; Schulte S
    Thromb Res; 2015 Aug; 136(2):388-95. PubMed ID: 26037285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational origin of the aggregation of recombinant human factor VIII.
    Grillo AO; Edwards KL; Kashi RS; Shipley KM; Hu L; Besman MJ; Middaugh CR
    Biochemistry; 2001 Jan; 40(2):586-95. PubMed ID: 11148054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on progressive strategies and recent trends in the production of recombinant human factor VIII.
    Mannully ST; L N R; Pulicherla KK
    Int J Biol Macromol; 2018 Nov; 119():496-504. PubMed ID: 30063930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A.
    Ramani K; Miclea RD; Purohit VS; Mager DE; Straubinger RM; Balu-Iyer SV
    J Pharm Sci; 2008 Apr; 97(4):1386-98. PubMed ID: 17705286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells.
    Becker S; Simpson JC; Pepperkok R; Heinz S; Herder C; Grez M; Seifried E; Tonn T
    Thromb Haemost; 2004 Jul; 92(1):23-35. PubMed ID: 15213841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of recombinant human B-domain-deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor.
    Oh HK; Lee JM; Byun TH; Park SY; Kim YH
    Biotechnol Prog; 2001; 17(6):1119-27. PubMed ID: 11735450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of aggregates of recombinant human factor VIII by size-exclusion chromatography and immunoassay.
    Cho Y; Garanchon C; Kashi R; Wong C; Besman MJ
    Biotechnol Appl Biochem; 1996 Aug; 24(1):55-9. PubMed ID: 8756394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible aggregation of recombinant bovine granulocyte-colony stimulating factor (bG-CSF) and implications for predicting protein shelf life.
    Roberts CJ; Darrington RT; Whitley MB
    J Pharm Sci; 2003 May; 92(5):1095-111. PubMed ID: 12712430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of the Factor VIII yield in mammalian cell cultures by reducing the membrane bound fraction.
    Kolind MP; Nørby PL; Berchtold MW; Johnsen LB
    J Biotechnol; 2011 Feb; 151(4):357-62. PubMed ID: 21219947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of lipidic cochleate containing recombinant factor VIII.
    Miclea RD; Varma PR; Peng A; Balu-Iyer SV
    Biochim Biophys Acta; 2007 Nov; 1768(11):2890-8. PubMed ID: 17936245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant factor VIII SQ--the influence of formulation parameters on structure and surface adsorption.
    Fatouros A; Sjöström B
    Int J Pharm; 2000 Jan; 194(1):69-79. PubMed ID: 10601686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of rFVIII inactivation with aggregation in solution.
    Wang W; Kelner DN
    Pharm Res; 2003 Apr; 20(4):693-700. PubMed ID: 12739780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic and thermodynamic analysis of thermal unfolding of recombinant erythropoietin.
    Arakawa T; Philo JS; Kita Y
    Biosci Biotechnol Biochem; 2001 Jun; 65(6):1321-7. PubMed ID: 11471731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.